Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-04-14
1999-02-23
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514299, 514300, 514305, 540593, 546112, 546113, 546138, A61K 3155, A61K 31435, C07D47104
Patent
active
058744274
ABSTRACT:
This invention provides novel 5-HT.sub.1F agonists of the Formula ##STR1## in which X, Y, E, R, A, B, and n are as defined in the specification, which are useful for the treatment of migraine and associated disorders.
REFERENCES:
patent: 5051412 (1991-09-01), Macor
patent: 5169947 (1992-12-01), Macor
patent: 5521196 (1996-05-01), Audia et al.
patent: 5521197 (1996-05-01), Audia
patent: 5604240 (1997-02-01), Chambers et al.
patent: 5708008 (1998-01-01), Audia et al.
Filla Sandra A.
Krushinski, Jr. Joseph H.
Schaus John Mehnert
Boone David E.
Dentz Bernard
Eli Lilly and Company
Titus Robert D.
LandOfFree
Substituted heteroaromatic 5-HT.sub.1F agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted heteroaromatic 5-HT.sub.1F agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heteroaromatic 5-HT.sub.1F agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-307155